June 10, 2026 · Form 4 insider transaction
MUIR GLENN P bought 29,835 shares of Cytek Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
1/36 of the total shares subject to the option shall vest monthly over 3 years following the grant date of June 10, 2026.